https://www.selleckchem.com/pr....oducts/Thiazovivin.h
ion model.Background Valve-in-valve transcatheter aortic valve implantation (TAVI) has emerged as a treatment for aortic bioprosthesis failure in case of prohibitive risk for redo surgery. However, clinical evaluation of valve-in-valve TAVI remains limited by the number of patients analysed. Aim To evaluate outcomes of valve-in-valve TAVI compared with native aortic valve TAVI at a nationwide level in France. Methods Based on the French administrative hospital discharge database, the study collected information for all consecutive p